Parkside Financial Bank & Trust’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $117K | Sell |
1,294
-7
| -0.5% | -$642 | 0.01% | 631 |
|
|
2025
Q4 | $117K | Sell |
1,301
-33
| -2% | -$3.13K | 0.01% | 637 |
|
|
2025
Q3 | $131K | Sell |
1,334
-22
| -2% | -$2.18K | 0.01% | 573 |
|
|
2025
Q2 | $124K | Buy |
1,356
+1,022
| +306% | +$98.8K | 0.01% | 586 |
|
|
2025
Q1 | $37.8K | Sell |
334
-68
| -17% | -$7.28K | ﹤0.01% | 924 |
|
|
2024
Q4 | $42.5K | Buy |
402
+46
| +13% | +$4.94K | 0.01% | 862 |
|
|
2024
Q3 | $38.4K | Sell |
356
-380
| -52% | -$41.5K | 0.01% | 868 |
|
|
2024
Q2 | $79.9K | Sell |
736
-98
| -12% | -$11.6K | 0.01% | 577 |
|
|
2024
Q1 | $110K | Buy |
834
+114
| +16% | +$14.2K | 0.02% | 492 |
|
|
2023
Q4 | $87.6K | Sell |
720
-36
| -5% | -$4.02K | 0.02% | 522 |
|
|
2023
Q3 | $84.8K | Buy |
756
+102
| +16% | +$13K | 0.02% | 461 |
|
|
2023
Q2 | $95.2K | Buy |
654
+15
| +2% | +$2.04K | 0.02% | 429 |
|
|
2023
Q1 | $82.6K | Sell |
639
-73
| -10% | -$9.16K | 0.02% | 440 |
|
|
2022
Q4 | $90.8K | Buy |
712
+15
| +2% | +$1.74K | 0.03% | 403 |
|
|
2022
Q3 | $72K | Sell |
697
-352
| -34% | -$38.6K | 0.02% | 416 |
|
|
2022
Q2 | $111K | Sell |
1,049
-163
| -13% | -$19.3K | 0.03% | 317 |
|
|
2022
Q1 | $155K | Buy |
1,212
+163
| +16% | +$19.6K | 0.04% | 270 |
|
|
2021
Q4 | $129K | Buy |
1,049
+49
| +5% | +$6.41K | 0.03% | 318 |
|
|
2021
Q3 | $142K | Sell |
1,000
-19
| -2% | -$2.79K | 0.04% | 258 |
|
|
2021
Q2 | $159K | Sell |
1,019
-1,140
| -53% | -$185K | 0.05% | 238 |
|
|
2021
Q1 | $335K | Buy |
2,159
+11
| +0.5% | +$1.7K | 0.1% | 141 |
|
|
2020
Q4 | $322K | Buy |
2,148
+32
| +2% | +$4.52K | 0.1% | 141 |
|
|
2020
Q3 | $279K | Buy |
2,116
+6
| +0.3% | +$784 | 0.1% | 141 |
|
|
2020
Q2 | $244K | Buy |
2,110
+10
| +0.5% | +$1.15K | 0.08% | 176 |
|
|
2020
Q1 | $207K | Sell |
2,100
-51
| -2% | -$6.68K | 0.08% | 167 |
|
|
2019
Q4 | $313K | Buy |
2,151
+1,189
| +124% | +$164K | 0.09% | 152 |
|
|
2019
Q3 | $128K | Buy |
962
+92
| +11% | +$11.9K | 0.04% | 237 |
|
|
2019
Q2 | $100K | Sell |
870
-30
| -3% | -$3.51K | 0.03% | 275 |
|
|
2019
Q1 | $111K | Sell |
900
-3
| -0.3% | -$341 | 0.04% | 248 |
|
|
2018
Q4 | $91K | Sell |
903
-68
| -7% | -$7.65K | 0.03% | 261 |
|
|
2018
Q3 | $124K | Sell |
971
-4
| -0.4% | -$476 | 0.04% | 223 |
|
|
2018
Q2 | $105K | Buy |
975
+39
| +4% | +$4.25K | 0.04% | 238 |
|
|
2018
Q1 | $99K | Buy |
936
+45
| +5% | +$5.23K | 0.04% | 235 |
|
|
2017
Q4 | $104K | Buy |
891
+24
| +3% | +$2.71K | 0.04% | 230 |
|
|
2017
Q3 | $98K | Sell |
867
-31
| -3% | -$3.58K | 0.04% | 225 |
|
|
2017
Q2 | $112K | Buy |
898
+34
| +4% | +$4.03K | 0.05% | 197 |
|
|
2017
Q1 | $102K | Buy |
864
+22
| +3% | +$2.49K | 0.04% | 206 |
|
|
2016
Q4 | $84K | Sell |
842
-151
| -15% | -$16.2K | 0.04% | 243 |
|
|
2016
Q3 | $125K | Buy |
993
+5
| +0.5% | +$618 | 0.06% | 203 |
|
|
2016
Q2 | $116K | Sell |
988
-358
| -27% | -$40.5K | 0.06% | 202 |
|
|
2016
Q1 | $139K | Buy |
1,346
+20
| +2% | +$1.94K | 0.07% | 184 |
|
|
2015
Q4 | $132K | Sell |
1,326
-168
| -11% | -$16.4K | 0.07% | 185 |
|
|
2015
Q3 | $137K | Buy |
+1,494
| New | +$150K | 0.08% | 169 |
|
Other funds holding ZBH
VCM
VPM
Parkside Financial Bank & Trust's ZBH Position: Q1 2026 in Review
Parkside Financial Bank & Trust reduced its Zimmer Biomet (ZBH) stake by 0.54% in Q1 2026, selling an estimated $642 and leaving 1,294 shares worth $117K. The position accounts for 0.01% of the portfolio, ranked #631.
Parkside Financial Bank & Trust first reported a position in ZBH in Q3 2015 and has held it in 43 quarters since. The position peaked at $335K in Q1 2021. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Parkside Financial Bank & Trust held 1,294 shares of Zimmer Biomet worth $117K as of Q1 2026.
- Parkside Financial Bank & Trust sold 7 Zimmer Biomet shares in Q1 2026, an estimated $642.
- Zimmer Biomet made up 0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #631 holding.
- Parkside Financial Bank & Trust first reported a position in Zimmer Biomet in Q3 2015 and has held it in 43 quarters since.
- Parkside Financial Bank & Trust's Zimmer Biomet position peaked at $335K in Q1 2021.
- 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.